532742 Stock Overview
Manufactures and sells specialty chemicals and intermediates in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Paushak Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5,947.75 |
| 52 Week High | ₹6,700.00 |
| 52 Week Low | ₹4,464.00 |
| Beta | 0.74 |
| 11 Month Change | 5.20% |
| 3 Month Change | 7.37% |
| 1 Year Change | -9.82% |
| 33 Year Change | -29.20% |
| 5 Year Change | 158.77% |
| Change since IPO | 2,245.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532742 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.07% | 1.7% | -1.0% |
| 1Y | -9.8% | 21.8% | 39.5% |
Return vs Industry: 532742 underperformed the Indian Chemicals industry which returned 21.8% over the past year.
Return vs Market: 532742 underperformed the Indian Market which returned 39.5% over the past year.
Price Volatility
| 532742 volatility | |
|---|---|
| 532742 Average Weekly Movement | 5.0% |
| Chemicals Industry Average Movement | 6.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.6% |
| 10% least volatile stocks in IN Market | 3.8% |
Stable Share Price: 532742 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532742's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 365 | Abhijit Joshi | www.paushak.com |
Paushak Limited manufactures and sells specialty chemicals and intermediates in India and internationally. It offers chloroformates, isocyanates, chlorides, carbonate/carbamate, and others. The company servers its products to pharmaceuticals, agrochemicals, and performance and custom synthesis industries.
Paushak Limited Fundamentals Summary
| 532742 fundamental statistics | |
|---|---|
| Market cap | ₹18.71b |
| Earnings (TTM) | ₹555.23m |
| Revenue (TTM) | ₹2.10b |
33.0x
P/E Ratio8.7x
P/S RatioIs 532742 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532742 income statement (TTM) | |
|---|---|
| Revenue | ₹2.10b |
| Cost of Revenue | ₹537.38m |
| Gross Profit | ₹1.56b |
| Other Expenses | ₹1.00b |
| Earnings | ₹555.23m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 180.15 |
| Gross Margin | 74.37% |
| Net Profit Margin | 26.48% |
| Debt/Equity Ratio | 0% |
How did 532742 perform over the long term?
See historical performance and comparison